Euronext - Delayed Quote EUR

(4N68S.NX)

Compare

1.0250

-0.1050

(-9.29%)

At close: 6:30:00 PM GMT+1

Twilio upgraded to Outperform by Baird, sets new $160 PT

Twilio (TWLO) stock is soaring after Baird analysts upgraded their recommendation following the company's investor day. The firm boosted Twilio to Outperform from Neutral and raised its price target to $160 per share, expressing confidence in Twilio's growth potential and ability to achieve double-digit revenue expansion. Market Domination hosts Julie Hyman and Josh Lipton explore the details of this upgrade. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith

Yahoo Finance Video 1 hour ago

TWLO
Novo Nordisk, Twilio, Texas Instruments: Market Minute

Yahoo Finance reporter Brooke DiPalma breaks down the latest stock market developments as part of this morning's Market Minute. Novo Nordisk (NVO) shares surged after the company reported breakthrough weight-loss drug trial results. The pharmaceutical company's injectable GLP-1 Amycretin medication demonstrated an impressive average weight loss of 22% over 36 weeks. Twilio (TWLO) stock is climbing as Wall Street analysts grow increasingly optimistic about its artificial intelligence potential. Analysts anticipate improved profitability through the company's expanding generative AI capabilities, including conversational AI technologies. Texas Instruments (TXN) experienced a stock decline after issuing a weaker-than-expected profit forecast for the first quarter. This pullback occurred despite the company's fiscal fourth quarter results beating expectations on both revenue and earnings. To watch more expert insights and analysis on the latest market action, check out more Wealth here. This post was written by Angel Smith

Yahoo Finance Video 6 hours ago

TWLO

TXN

NONOF
Novo Nordisk stock surges on trial results for injectable GLP-1

Novo Nordisk (NVO) shares are surging by nearly 11% in Friday's pre-market trading after releasing positive early trial results for the company's injectable GLP-1 weight-loss drug, amycretin. Yahoo Finance senior health reporter Anjalee Khemlani breaks down these trial results and the position it gives Novo Nordisk in better competing with Eli Lilly's (LLY) newer emerging GLP-1 treatments. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 8 hours ago

NONOF

NVO
Aclarion Announces Reverse Stock Split

BROOMFIELD, CO - January 24, 2025 (NEWMEDIAWIRE) - Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians...

NewMediaWire 37 minutes ago

ACON

ACONW
Why Eli Lilly Stock Topped the Market Today

Eli Lilly (NYSE: LLY) stock was the picture of health on Friday. Shares of the massive American pharmaceutical company rose by more than 2% on the day, thanks largely to news from a rival. Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy, which competes directly with Eli Lilly's Zepbound.

Motley Fool 39 minutes ago

LLY

NVO

^GSPC
Stock Market Today: Indexes Close Near Day's Lows; Nvidia Ends Winning Streak, Tesla Reverses Lower (Live Coverage)

Dow Jones dragged along in the stock market today. The Nasdaq composite sank below the 20,000 level and small caps joined the sell-off.

Investor's Business Daily 1 hour ago

NONOF

NVO

ISRG
Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms

Novo Nordisk stock surged Friday after the obesity kingpin reported strong results for its next-generation weight-loss drug, amycretin.

Investor's Business Daily 1 hour ago

NONOF

NVO

LLY
Verizon Communications (VZ) Q4 2024 Earnings Call Transcript

VZ earnings call for the period ending December 31, 2024.

Motley Fool 1 hour ago

VZ
Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk

Allurion catapulted Friday after the company said it plans to test its weight-loss technology with an obesity drug.

Investor's Business Daily 1 hour ago

NONOF

NVO

ALUR
Mullen Reports Improved 2024 Financial Results

Company finishes the 2024 fiscal year with growth of national dealer network, increased sales and delivery of vehicles Fiscal year 2024 reduction of $85.4M in cash spend compared to fiscal year 2023 Successful launch of Bollinger Motors B4 production and sales Company now has three EV production lines in the U.S. with national sales and service networks supporting Mullen Class 1 and 3 and Bollinger Class 4 commercial vehicles Company announces further increase in operational efficiencies driving

GlobeNewswire 1 hour ago

MULN
Market Chatter: Middleby Shares Rise After New Activist Investor Buys Shares, Seeks Changes

Middleby (MIDD) advanced 16% Friday, after reports that activist investor Ed Garden will soon press

PREMIUM
MT Newswires 2 hours ago

MIDD
NextEra Energy Is Today’s Top S&P 500 Stock After Revenue Miss. Here’s Why.

The renewable-energy company plans to capitalize on the demand for power driven by AI and data centers.

Barrons.com 2 hours ago

NEE-PT
Why NextEra Energy Stock Jumped More Than 5% Today

The clean energy stock could climb even higher in 2025.

Motley Fool 3 hours ago

NEE-PT
Middleby Skyrockets 15%--Activist Shake-Up and Big Moves Fuel Stock Surge

Ed Garden's activist firm takes a stake, Middleby restructures, and Wall Street bets big--what's next for the kitchen giant?

GuruFocus.com 3 hours ago

MIDD
Why NextEra (NEE) Stock Is Advancing Today

NextEra Energy (NEE) is rising 5% today after the firm announced that it was taking steps to boost its natural gas and nuclear output in order to meet the surging demand for electricity. The latter trend is being sparked by the AI boom. A New Partnership and a Nuclear Initiative On NextEra’s fourth-quarter earnings call […]

Insider Monkey 3 hours ago

NEE-PT
Middleby (MIDD) Stock Trades Up, Here Is Why

Shares of kitchen product manufacturer Middleby (NYSE:MIDD) jumped 15.1% in the afternoon session after The Wall Street Journal reported that activist Garden Investments built a ~5% stake in the company and plans to push for changes. This move is noteworthy given that activist investors often bring about significant changes in targeted companies, focusing on improving asset monetization, expense efficiency, and stock buybacks.

StockStory 3 hours ago

MIDD
These Stocks Are Moving the Most Today: Texas Instruments, Meta, Verizon, Boeing, Tesla, Amex, Novo Nordisk, and More

Texas Instruments falls after the chip maker’s first-quarter earnings forecast misses estimates, Boeing declines after revealing it expects to post a wider fourth-quarter loss because of strikes at the aerospace giant, and Meta Platforms plans to invest up to $65 billion in 2025 to build out its AI infrastructure.

Barrons.com 4 hours ago

TXN

BA

TWLO
Twilio Stock Soars 22% as AI Demand Surges--But Wall Street Remains Divided

Explosive growth, bullish forecasts, and AI momentum--yet Wall Street remains divided on Twilio's true value.

GuruFocus.com 4 hours ago

TWLO
Top Midday Gainers

Nvni Group (NVNI) said late Thursday that it regained compliance with Nasdaq's minimum closing bid p

PREMIUM
MT Newswires 4 hours ago

TWLO
Renewables Leader NextEra Expanding Gas, Nuclear for AI Boom

(Bloomberg) -- NextEra Energy Inc., one of the world’s biggest suppliers of wind and solar power, is moving to expand its natural gas and nuclear generation in a bid to meet the surging demand for electricity sparked by artificial intelligence. Most Read from BloombergWhat Happened to Hanging Out on the Street?How Sanctuary Cities Are Preparing for Another Showdown With TrumpBillionaire Developer Caruso Slams LA Leadership Over WildfiresVienna Embraces Heat Pumps to Ditch Russian GasHoboken PATH

Bloomberg 4 hours ago

NEE-PT

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

(4N68S.NX)

Related News

Twilio upgraded to Outperform by Baird, sets new $160 PT

Novo Nordisk, Twilio, Texas Instruments: Market Minute

Novo Nordisk stock surges on trial results for injectable GLP-1

Aclarion Announces Reverse Stock Split

Why Eli Lilly Stock Topped the Market Today

Stock Market Today: Indexes Close Near Day's Lows; Nvidia Ends Winning Streak, Tesla Reverses Lower (Live Coverage)

Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms

Verizon Communications (VZ) Q4 2024 Earnings Call Transcript

Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk

Mullen Reports Improved 2024 Financial Results

Market Chatter: Middleby Shares Rise After New Activist Investor Buys Shares, Seeks Changes

NextEra Energy Is Today’s Top S&P 500 Stock After Revenue Miss. Here’s Why.

Why NextEra Energy Stock Jumped More Than 5% Today

Middleby Skyrockets 15%--Activist Shake-Up and Big Moves Fuel Stock Surge

Why NextEra (NEE) Stock Is Advancing Today

Middleby (MIDD) Stock Trades Up, Here Is Why

These Stocks Are Moving the Most Today: Texas Instruments, Meta, Verizon, Boeing, Tesla, Amex, Novo Nordisk, and More

Twilio Stock Soars 22% as AI Demand Surges--But Wall Street Remains Divided

Top Midday Gainers

Renewables Leader NextEra Expanding Gas, Nuclear for AI Boom